Management of Polycythemia in Neonates

Risks and Complications of Exchange Transfusion

Exchange transfusion carries a significant mortality risk of approximately 3 per 1000 procedures, and significant morbidity occurs in up to 5% of exchange transfusions, including apnea, bradycardia, cyanosis, vasospasm, thrombosis, and necrotizing enterocolitis, in term infants with polycythemia 1, 2
Hypoxic-ischemic encephalopathy has occurred in otherwise healthy infants receiving exchange transfusions, highlighting the need for careful consideration of the risks and benefits of this procedure 1, 2
The procedure should only be performed by trained personnel in a neonatal intensive care unit with full monitoring and resuscitation capabilities, to minimize the risks of complications 3

Continuous cardiac monitoring is recommended for neonates with polycythemia and cardiac arrhythmia, to closely monitor the irregular rhythm and detect any potential complications 1, 2
A 12-lead ECG should be obtained to characterize the arrhythmia, and to guide further management and treatment 4
Calcium levels should be checked, as large blood volume shifts can affect calcium homeostasis, and to monitor for potential complications 4
Monitoring for signs of hyperviscosity syndrome, such as respiratory distress, poor feeding, and lethargy, is essential to guide management and treatment 4

Partial exchange transfusion should be considered only if the hematocrit rises to ≥70% despite conservative management, or if severe symptomatic hyperviscosity develops, such as seizures, severe respiratory distress, or renal failure 4
Thrombotic complications are a potential risk of polycythemia, and exchange transfusion may be considered if these occur, to prevent further complications 1
Neonates have limited capacity for glycogenolysis and gluconeogenesis, and reduced dextrose infusion rates can precipitate hypoglycemia, highlighting the need for careful management of glucose infusion rates during any blood sampling or procedures 5